Several studies have demonstrated the existence of an association between high C5aR1 expression and poor outcomes in head and neck squamous cell carcinoma [10], gastric cancer [23], breast cancer [24], and glioblastoma [25]. This evidence concerns the gene C5AR1 and breast carcinoma.